Stay in touch with NCATS by connecting via social media, joining our listserv for frequent announcements, and subscribing to our monthly e-newsletter.
Explore the full spectrum of translational science, including NCATS' role in transforming knowledge into treatments.
Review a list of all the innovative programs and initiatives that NCATS supports.
NCATS and Duke University scientists help advance a gene therapy for Pompe disease into clinical testing for the first time.
A team of NCATS scientists and collaborators have uncovered a potential strategy against Huntington’s disease that may also be relevant to a range of neurodegenerative disorders.
This March 1, 2018 event features interactive panel discussions, posters, exhibits, tours and more. Register now.
Read about rare immune disorders research, CTSA Program training success stories, a new video about NCATS’ work to help patients with rare diseases, and more.
NCATS Rare Diseases Clinical Research Network scientists are conducting natural history studies and defining rare genetic diseases.
CTSA Program Fosters Next Generation of Translational Scholars.
Watch the new NCATS Rare Diseases Research Video, narrated by Dr. Petra Kaufmann.
Christopher P. Austin, M.D.
Funded activities under the NCATS Clinical and Translational Science Awards (CTSA) Program (PDF - 80KB)
Interested in creating biologically, physiologically and pharmacologically relevant assays for early-stage drug discovery? Check out our best-practices Assay Guidance Manual.
Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.
More News & Events …